Article info
PDFImage of the moment
Impulse control disorder manifesting as hidden sexual self-injury
- Correspondence to Dr Philip Duffey, Department of Neurology, York Hospital, Wigginton Road, York YO23 1YP, UK; phil.duffey{at}york.nhs.uk
Citation
Impulse control disorder manifesting as hidden sexual self-injury
Publication history
- Accepted February 22, 2015
- First published March 31, 2015.
Online issue publication
May 14, 2015
Article Versions
- Previous version (31 March 2015).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study
- Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management
- Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial
- Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels
- ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson’s disease
- Sleep and REM sleep behaviour disorder in Parkinson’s disease with impulse control disorder
- Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic
- Extrastriatal dopaminergic changes in Parkinson’s disease patients with impulse control disorders
- Increased risk of impulse control symptoms in Parkinson's disease with REM sleep behaviour disorder
- Initial drug treatment in Parkinson’s disease